logo/base Created with Sketch.

Shaping liver health, enabling metabolic care

FibroScan® by Echosens has been delivering fast, non-invasive insights into liver fibrosis (stiffness) and steatosis (fat) for over 25 years. Supporting cardiometabolic care, it enables early detection and personalized patient management across the entire spectrum of liver disease. 

A FibroScan® for every setting

Explore our range of non-invasive point-of care solutions that support diagnosis, risk stratification, and monitoring of metabolic liver disease across various specialties.

Discover our solutions chevron

Our Next-Generation FibroScan® Technology

Discover the power of Guided VCTE® - improved guidance designed to support streamlined and efficient exams.

Learn more about Guided VCTE chevron

The leader in non-invasive metabolic care through liver diagnostics, trusted across specialties worldwide

What makes FibroScan® the gold standard solution across the chronic liver disease spectrum? Only the FibroScan® device is equipped with the VCTE® elastography system, the proprietary solution trusted in clinical practice, research, and global guidelines.

If it’s FibroScan®, it’s VCTE®. No substitutes. No shortcuts.

Discover all of our FibroScan solutions

Our liver health assessment solutions

Beyond FibroScan®, Echosens develops solutions to optimize the management of liver diseases and assist in guiding treatment decisions.

  • Liver Health Management

    Liver Health Management

    Cloud-based platform with clinical decision support tools
    chevron
  • Scores FibroScan® based

    FibroScan®-based Scores

    Enhancing FibroScan® liver disease assessment with biological markers
    chevron
  • FibroScan® Guided VCTE

    Guided VCTE®

    The next-generation FibroScan® technology
    chevron

  • Trade-in Program

    Access the latest generation FibroScan®
    chevron

Who we are

As a pioneer and leader in the liver health field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health.

FibroScan® is recognized worldwide as the reference for non-invasive liver fibrosis and liver steatosis assessment with more than 6,270+ peer-reviewed publications and 250+ international guidelines.

Echosens has made FibroScan® available in over 127+ countries enabling millions of liver examinations worldwide.

Learn more about Echosens Locate us

Over 6,270+ peer-reviewed publications and 250 international guidelines

Discover the scientific foundation behind Echosens’ non‑invasive liver assessment technologies. As the global gold standard in liver elastography, FibroScan® and its validated biomarkers are supported by thousands of peer‑reviewed publications and international guidelines, demonstrating robust clinical performance in the evaluation and monitoring of chronic liver disease.

Discover the clinical evidence

What our users say

I always say that FibroScan is the hepatologist’s stethoscope, and the LSM by VCTE and CAP measurements are the liver’s vital signs.

Dr. Naim Alkhouri

Hepatologist

When we introduced FibroScan, we saw it as a real opportunity to make a meaningful impact on our community. Liver disease is far more common than most people realize, and being able to identify risk earlier can change a patient’s trajectory. FibroScan gives us a way to reach people sooner and guide them toward the care they need.

Dr. Bradley Anderson

Gastroenterologist

As a clinical researcher, I rely heavily on FibroScan to select the right patient for the right study. Clinical trials in non-alcoholic steatohepatitis typically include patients with specific fibrosis stages. It is thus important to have reliable fibrosis assessment and avoid unnecessary liver biopsies.

Vincent Wong

Hepatologist from Hong Kong

Read all testimonies chevron